Factor V Leiden mutation and risk of VTE with HRTPlaceboCoronary Artery DiseasePostmenopausal WomanHormone Replacement TherapyAdjust Odds Ratiodoi:10.2165/00128415-200209150-00003NoneReactions Weekly
GENETEST REVIEW Genetics in Medicine Factor V Leiden thrombophilia Jody Lynn Kujovich, MD TABLE OF CONTENTS Pathogenic mechanisms and molecular basis ...2 Prevalence...2 Diagnosis...
Summary. Background: Pregnancy, oral contraceptive (OC) use and hormone replacement therapy (HRT) are established risk factors for venous thrombosis. Acquired resistance to activated protein C (APC) has been proposed to contribute to the increased thrombosis risk. Mouse models are often used for pr...
mRNA gene expression levels normalized against gene coding for RAS-associated protein (RAB7A) in the corneal endothelium (CE) from FECD patients and non-FECD controls for (a) factor V (F5) gene and (b) aquaporin 1 (AQP1) gene. mRNA gene expression levels normalized againstRAB7Ain CE fro...
i Protein-oder Enzymbanden in einem (granulierten) Sephadex- Flachgel, in welchem eine präparative 7 Isotachophorese oder 7 iso- elektrische Fokussierung durchgeführt wurde, visualisiert man mit einem Papierabklatsch. Da man Proteinbanden in granulierten Gelen nicht anfärben kann, nimmt ...
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden miceAPC resistancemousepregnancyprotein STFPISummary. Background: Pregnancy, oral contraceptive (OC) use and hormone replacement therapy (HRT) are established risk factors for venous thrombosis. Acquired resistance to...
( 1998 ) Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries . Heart , 80 , 338 – 340 .Dacosta A, Tardy-Poncet B, Isaaz K, et al. Prevalence of factor V Leiden (APCR) and other inherited ...
Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart. 1998;80(4):338-40.Dacosta A, Tardy-Poncet B, Isaaz K, et al. Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in...
Verbindungen der Formel (IIa) können hergestellt werden durch Cyclisieren einer Verbindung der Formel (IV), wobei p für 1 steht und Ra eine geeignete Schutzgruppe für die Aminogruppe ist. Das Aktivieren der Hydroxygruppe wird ausgeführt durch Umwandlung in eine geeignete Abgangsgruppe, wie...
Factor V Leiden mutation and risk of VTE with HRTdoi:10.2165/00128413-200213510-00040SpringerInpharma Weekly